Skip to main content
Premium Trial:

Request an Annual Quote

Centogene Gets CE-IVD Mark for Cloud-Based Genetic Diagnostics Software Platform

NEW YORK – Centogene said on Wednesday that it has obtained the CE mark for its cloud-based software-as-a-service platform CentoCloud, which provides clinical decision support for the diagnosis of genetic diseases.

CentoCloud, which is used for the identification, prioritization, and classification of genetic variants, allows laboratories to establish next-generation sequencing-based diagnostic testing. According to the company, it is one of the few examples of CE-marked, cloud-based software for genomic diagnostics.

"With the new IVD regulation going into place later this week, CentoCloud will be one of Europe's only commercialized software on market — underlining our commitment to being at the forefront of offering safe and accessible patient solutions," said Centogene CEO Kim Stratton in a statement, referring to Europe's new In Vitro Diagnostic Regulation (IVDR), which will go into effect May 26.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.